IVIG Maintenance Frequency for MOGAD
I cannot provide a definitive recommendation for IVIG maintenance frequency in MOGAD (Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease) because none of the provided evidence addresses MOGAD specifically—all references discuss other conditions (Rasmussen syndrome, cardiac transplant rejection, rheumatic diseases, myasthenia gravis, pemphigus, ITP, and primary immunodeficiency).
Critical Issue: Wrong Disease Context
The evidence provided is entirely irrelevant to your question about MOGAD. The expanded question incorrectly substitutes "myasthenia gravis" for MOGAD, which are completely different neuroinflammatory conditions with distinct pathophysiology and treatment paradigms.
What the Evidence Actually Shows (For Other Conditions)
While I cannot answer your MOGAD question, the evidence does reveal IVIG dosing patterns for other autoimmune conditions:
For Myasthenia Gravis (NOT MOGAD):
- Maintenance dosing: 400 mg/kg monthly or 1 g/kg every 3-4 weeks 1, 2
- Initial loading: 400 mg/kg/day for 5 days, then monthly maintenance 1
- Some protocols use 1-2 g/kg monthly 3, 4
For Rasmussen Syndrome:
- Maintenance: 1 g/kg every 4 weeks 5
For Primary Immunodeficiency:
- 300-600 mg/kg every 3-4 weeks 6
What You Need Instead
For MOGAD-specific guidance, you would need:
- MOGAD treatment guidelines or consensus statements
- Studies specifically examining IVIG in MOGAD patients
- Evidence comparing IVIG to other MOGAD maintenance therapies (rituximab, azathioprine, mycophenolate)
The dosing frequency for MOGAD may differ substantially from myasthenia gravis due to different disease mechanisms, relapse patterns, and treatment goals.